These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24070404)

  • 1. Amyotrophic lateral sclerosis disease progression model.
    Gomeni R; Fava M;
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):119-29. PubMed ID: 24070404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Item response theory analysis of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised in the Pooled Resource Open-Access ALS Clinical Trials Database.
    Bacci ED; Staniewska D; Coyne KS; Boyer S; White LA; Zach N; Cedarbaum JM;
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(3-4):157-67. PubMed ID: 26473473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression.
    Karanevich AG; Statland JM; Gajewski BJ; He J
    BMC Med Res Methodol; 2018 Feb; 18(1):19. PubMed ID: 29409450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classifying Patients with Amyotrophic Lateral Sclerosis by Changes in FVC. A Group-based Trajectory Analysis.
    Ackrivo J; Hansen-Flaschen J; Jones BL; Wileyto EP; Schwab RJ; Elman L; Kawut SM
    Am J Respir Crit Care Med; 2019 Dec; 200(12):1513-1521. PubMed ID: 31322417
    [No Abstract]   [Full Text] [Related]  

  • 5. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
    Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
    No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RandomForest4Life: a Random Forest for predicting ALS disease progression.
    Hothorn T; Jung HH
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):444-52. PubMed ID: 25141076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients.
    Reich-Slotky R; Andrews J; Cheng B; Buchsbaum R; Levy D; Kaufmann P; Thompson JL
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):212-6. PubMed ID: 23452274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
    Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
    J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
    Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
    J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A speech measure for early stratification of fast and slow progressors of bulbar amyotrophic lateral sclerosis: lip movement jitter.
    Rong P; Yunusova Y; Eshghi M; Rowe HP; Green JR
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):34-41. PubMed ID: 31694409
    [No Abstract]   [Full Text] [Related]  

  • 12. A model incorporating ultrasound to predict the probability of fast disease progression in amyotrophic lateral sclerosis.
    Toh TH; Abdul-Aziz NA; Yahya MA; Goh KJ; Loh EC; Capelle DP; Shahrizaila N
    Clin Neurophysiol; 2021 Oct; 132(10):2722-2728. PubMed ID: 34312065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials.
    Daghlas I; Lever TE; Leary E
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):206-211. PubMed ID: 29260911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratifying disease stages with different progression rates determined by electrophysiological tests in patients with amyotrophic lateral sclerosis.
    Liu XX; Zhang J; Zheng JY; Zhang S; Xu YS; Kang DX; Fan DS
    Muscle Nerve; 2009 Mar; 39(3):304-9. PubMed ID: 19208412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients.
    Watanabe H; Atsuta N; Nakamura R; Hirakawa A; Watanabe H; Ito M; Senda J; Katsuno M; Izumi Y; Morita M; Tomiyama H; Taniguchi A; Aiba I; Abe K; Mizoguchi K; Oda M; Kano O; Okamoto K; Kuwabara S; Hasegawa K; Imai T; Aoki M; Tsuji S; Nakano I; Kaji R; Sobue G
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):230-6. PubMed ID: 25548957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the Pooled Resource Open-Access ALS Clinical Trials cohort.
    Thakore NJ; Lapin BR; Pioro EP;
    Muscle Nerve; 2018 Jun; 57(6):937-945. PubMed ID: 29244213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creatine Kinase and Progression Rate in Amyotrophic Lateral Sclerosis.
    Ceccanti M; Pozzilli V; Cambieri C; Libonati L; Onesti E; Frasca V; Fiorini I; Petrucci A; Garibaldi M; Palma E; Bendotti C; Fabbrizio P; Trolese MC; Nardo G; Inghilleri M
    Cells; 2020 May; 9(5):. PubMed ID: 32397320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.
    Rooney J; Burke T; Vajda A; Heverin M; Hardiman O
    J Neurol Neurosurg Psychiatry; 2017 May; 88(5):381-385. PubMed ID: 27888187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
    Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALSFRS and appel ALS scores: discordance with disease progression.
    Voustianiouk A; Seidel G; Panchal J; Sivak M; Czaplinski A; Yen A; Appel SH; Lange DJ
    Muscle Nerve; 2008 May; 37(5):668-72. PubMed ID: 18288708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.